医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Rapid Nutrition Appoints Octa Phillip Securities Limited Global Markets Service

2013年01月10日 AM12:25
このエントリーをはてなブックマークに追加


 

BRISBANE, Australia

Global natural healthcare company Rapid Nutrition announced today that it has appointed diversified investment and financial services group Octa Phillip Securities Limited, to provide access to their electronic trading platform and services to Rapid Nutrition shareholders.

Octa Phillip provides wealth management, institutional and private client stockbroking, corporate finance, research and funds management services and has direct channels into Asia. Octa Phillip’s offices are in Melbourne, Sydney, Perth, Adelaide and the Gold Coast. It was formed by the Intersuisse Ltd acquisition of the Austock Securities business in early 2012.

“We look forward to furthering our ongoing relationship with Octa Phillip and to now being publicly listed on the GXG Stock Exchange,” said Rapid Nutrition Managing Director Simon St. Ledger. “This relationship will make it easier for our shareholders to trade in Rapid Nutrition shares and will help our company continue to grow in providing the best health and wellness products across the globe.” Rapid Nutrition began trading on the GXG Markets OTC under the symbol RNL in November.”

Nicholas Pereza-Mathews, Head of Global Markets at Octa Phillip Securities, added that their global markets service provides a custody and dealing service for shareholders in Australian companies that have listed on overseas exchanges.

Earlier this year, Rapid Nutrition announced the purchase of a 15 percent stake in Motivate Health Technology, a U.S.-based health technology company, to create a revolutionary weight loss video app to further support the company’s premium weight loss program.

About Rapid Nutrition

Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry. For more information, please visit http://rapid-nutrition.com

CONTACT

Rapid Nutrition
Simon St Ledger, +61 7 3200 4222
media@rapid-nutrition.com

同じカテゴリーの記事 

  • Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)